The partnership between the US military and the body and the non-profit will examine three drugs as potential therapies ...

The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

MSD has commenced the Phase III trial to assess zilovertamab vedotin combined with R-CHP to treat individuals with previously ...

Early detection and public health interventions are critical in improving sepsis survival rates and limiting its long-term ...

Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in ...

Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of ...